Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Annala

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Journal of Hematology & Oncology|October 11, 2014
Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcomaJilong Yang, Matti Annala, Ping Ji, et al.
BMC Cancer|May 5, 2017
Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomasBirgitta Lehtinen, Annina Raita, Juha Kesseli, et al.
Cold Spring Harbor Molecular Case Studies|April 1, 2018
Whole-exome sequencing identifies germline mutation in <i>TP53</i> and <i>ATRX</i> in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytomaKristiina Nordfors, Joonas Haapasalo, Ebrahim Afyounian, et al.
Histology and Histopathology|October 30, 2019
Moderate-to-strong expression of FGFR3 and TP53 alterations in a subpopulation of choroid plexus tumorsKirsi J Granberg, Annina Raita, Birgitta Lehtinen, et al.
Cell Reports|October 5, 2025
Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancerJussi Nikkola, Lauri Ryyppö, Juuso Vuorinen, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancerG Steven Bova, Heini M L Kallio, Matti Annala, et al.
Nature Communications|March 23, 2018
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progressionLeena Latonen, Ebrahim Afyounian, Antti Jylhä, et al.
Plos One|March 4, 2016
Microseminoprotein-Beta Expression in Different Stages of Prostate CancerLiisa Sjöblom, Outi Saramäki, Matti Annala, et al.
Life Science Alliance|April 5, 2024
Sensitive circulating tumor DNA-based residual disease detection in epithelial ovarian cancerHeini Ml Kallio, Kalle Savolainen, Tuomo Virtanen, et al.
The Journal of Pathology|September 26, 2012
Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human gliomaLynette M Moore, Virpi Kivinen, Yuexin Liu, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Hematology & Oncology|October 11, 2014
Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcomaJilong Yang, Matti Annala, Ping Ji, et al.
BMC Cancer|May 5, 2017
Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomasBirgitta Lehtinen, Annina Raita, Juha Kesseli, et al.
Cold Spring Harbor Molecular Case Studies|April 1, 2018
Whole-exome sequencing identifies germline mutation in <i>TP53</i> and <i>ATRX</i> in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytomaKristiina Nordfors, Joonas Haapasalo, Ebrahim Afyounian, et al.
Histology and Histopathology|October 30, 2019
Moderate-to-strong expression of FGFR3 and TP53 alterations in a subpopulation of choroid plexus tumorsKirsi J Granberg, Annina Raita, Birgitta Lehtinen, et al.
Cell Reports|October 5, 2025
Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancerJussi Nikkola, Lauri Ryyppö, Juuso Vuorinen, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancerG Steven Bova, Heini M L Kallio, Matti Annala, et al.
Nature Communications|March 23, 2018
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progressionLeena Latonen, Ebrahim Afyounian, Antti Jylhä, et al.
Plos One|March 4, 2016
Microseminoprotein-Beta Expression in Different Stages of Prostate CancerLiisa Sjöblom, Outi Saramäki, Matti Annala, et al.
Life Science Alliance|April 5, 2024
Sensitive circulating tumor DNA-based residual disease detection in epithelial ovarian cancerHeini Ml Kallio, Kalle Savolainen, Tuomo Virtanen, et al.
The Journal of Pathology|September 26, 2012
Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human gliomaLynette M Moore, Virpi Kivinen, Yuexin Liu, et al.
Pageof 7